Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study

BACKGROUND AND OBJECTIVES: Subcutaneous immunoglobulin (SCIG) therapy is becoming increasingly popular as self-administration is possible because intravenous access is unnecessary, and there is a lower frequency of systemic adverse events. The aim of this study was to evaluate the shifting from intr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Drug Investig
Autori principali: Vultaggio, Alessandra, Azzari, Chiara, Milito, Cinzia, Finocchi, Andrea, Toppino, Claudia, Spadaro, Giuseppe, Trizzino, Antonino, Baldassarre, Martire, Paganelli, Roberto, Moschese, Viviana, Soresina, Annarosa, Matucci, Andrea
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2015
Soggetti:
Original Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335091/
https://ncbi.nlm.nih.gov/pubmed/25672929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-015-0270-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi